Patent · US Active

Purification of montelukast

US7812168B2 · kind B2 · utility

1Cited by
16References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 5, 2006
Grant dateOct 12, 2010
Priority date
Expiry dateMar 26, 2029

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P37/08
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides methods of purifying montelukast, a new isolated impurity of montelukast, method for its isolation, and method of using montelukast impurity as a reference marker and a reference standard.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.